Kazia Therapeutics-Spon ADRKZIA
13F holders, Q4 2025 (December 31)22holders +11
11new positions
1sold out
1famous investor
$6.88avg. 13F price*
At the end of Q4 2025, 22 institutions reported holding Kazia Therapeutics-Spon ADR (KZIA) in their 13F filings, up 11 from Q3 2025. 11 opened new positions and 1 sold out. The largest holders were Alyeska Investment Group, L.P. ($5.1M), Stonepine Capital Management, LLC ($3.2M) and Bleichroeder LP ($2.8M). One famous investor held it Steve Cohen (0.0% of Point72 Asset Management's portfolio).
- Company
- Kazia Therapeutics-Spon ADR
- CUSIP
- 48669G303
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 11 | $15.6M |
| Exits | 1 | $375 |
All 13F filers, Q3 2025 → Q4 2025: 2,273,582 shares bought and 122,179 shares sold, net +2,151,403 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 22 holders
| Alyeska Investment Group, L.P. | 0.01% | New | 738,321 | $5.1M |
| Stonepine Capital Management, LLC | 2.51% | New | 460,359 | $3.2M |
| Bleichroeder LP | 0.49% | New | 400,000 | $2.8M |
| Velan Capital Investment Management LP | 1.20% | New | 300,000 | $2.1M |
| Point72 Asset Management | 0.00% | New | 200,000 | $1.4M |
| Empery Asset Management, LP | 1.04% | — | 170,000 | $1.2M |
| Corsair Capital Management, L.P. | 0.08% | New | 70,000 | $470K |
| Royal Bank of Canada | 0.00% | New | 54,133 | $373K |
| Westside Investment Management, Inc. | 0.03% | New | 30,875 | $213K |
| Barclays PLC | 0.00% | Reduce 0.0% | 23,999 | $165K |
| Rockefeller Capital Management L.P. | 0.00% | No change | 10,700 | $74K |
| Engineers Gate Manager LP | 0.00% | New | 10,388 | $72K |
| FNY Investment Advisers, LLC | 0.01% | New | 7,500 | $51K |
| Rhumbline Advisers | 0.00% | Add +164.8% | 1,565 | $11K |
| Morgan Stanley | 0.00% | Add +400.0% | 1,000 | $7K |
| GAMMA Investing LLC | 0.00% | New | 232 | $2K |
| Arax Advisory Partners | 0.00% | No change | 200 | $1K |
| UBS Group AG | 0.00% | Reduce -94.5% | 193 | $1K |
| Osaic Holdings, Inc. | 0.00% | No change | 10 | $68 |
| Citigroup Inc. | 0.00% | Reduce -99.8% | 1 | $7 |
| Allworth Financial LP | 0.00% | No change | 1 | $7 |
| Dauntless Investment Group, LLC | 0.00% | Reduce -100.0% | 1 | $7 |
"% of holder's portfolio" is KZIA's weight in each manager's 13F, not the share of Kazia Therapeutics-Spon ADR the manager owns.